Rocket


News + Filings
Transactions





REED ELIZABETH E

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/10/2023Travere Therapeutics, Inc.RTRXSaleCommon Stock825$16.59$13.7k 05/10/2023
01/24/2023Travere Therapeutics, Inc.RTRXSaleCommon Stock2.1k$21.50$44.3k 01/24/2023
05/12/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock1k$21.51$22.6k 05/10/2022
05/10/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock900$21.51$19.4k 05/10/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantCommon Stock9.8k$0.00$0 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock1.4k$27.40$37k 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantEmployee stock option (right to buy)39.4k$27.50$1.1M 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantPerformance-based restricted stock units9.8k$0.00$0 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantPerformance-based restricted stock units8k$0.00$0 01/31/2022
01/24/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock2.2k$24.98$56.2k 01/24/2022
01/11/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock5k$27.40$137k 01/10/2022
01/10/2022Travere Therapeutics, Inc.RTRXGrantCommon Stock5k$0.00$0 01/10/2022
05/12/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock1.6k$19.46$31.6k 05/11/2021
05/11/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock1.6k$19.14$31.1k 05/11/2021
02/08/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock2.2k$31.58$71.1k 02/05/2021
02/05/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock2.2k$31.41$70.7k 02/05/2021
02/03/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock2.5k$28.91$72.3k 02/03/2021
02/03/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock675$28.91$19.5k 02/03/2021
02/03/2021Travere Therapeutics, Inc.RTRXGrantCommon Stock4.5k$0.00$0 02/03/2021
02/02/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock2.5k$30.75$76.9k 01/31/2021
02/02/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock675$30.75$20.8k 01/31/2021
01/31/2021Travere Therapeutics, Inc.RTRXGrantCommon Stock5k$0.00$0 01/31/2021
01/21/2021Travere Therapeutics, Inc.RTRXGrantEmployee stock option (right to buy)57.5k$26.88$1.5M 01/21/2021
01/21/2021Travere Therapeutics, Inc.RTRXGrantCommon Stock15k$0.00$0 01/21/2021
01/06/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock688$27.01$18.6k 01/05/2021
01/05/2021Travere Therapeutics, Inc.RTRXSaleCommon Stock688$26.65$18.3k 01/05/2021
11/16/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock2.5k$23.98$60k 11/16/2020
11/13/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock2.5k$23.62$59k 11/11/2020
11/11/2020Travere Therapeutics, Inc.RTRXGrantCommon Stock5k$0.00$0 11/11/2020
09/23/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock1.5k$18.48$27.7k 09/23/2020
09/22/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock1.5k$18.59$27.9k 09/18/2020
09/18/2020Travere Therapeutics, Inc.RTRXGrantCommon Stock3k$0.00$0 09/18/2020
05/12/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock525$17.16$9k 05/11/2020
05/12/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock527$16.98$9k 05/11/2020
05/11/2020Travere Therapeutics, Inc.RTRXSaleCommon Stock525$14.95$7.8k 05/11/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy